Cargando…
Blood transfusion and the anaesthetist: management of massive haemorrhage
1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised imm...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032944/ https://www.ncbi.nlm.nih.gov/pubmed/20963925 http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x |
_version_ | 1782197516955025408 |
---|---|
author | Thomas, D Wee, M Clyburn, P Walker, I Brohi, K Collins, P Doughty, H Isaac, J Mahoney, PF Shewry, L |
author_facet | Thomas, D Wee, M Clyburn, P Walker, I Brohi, K Collins, P Doughty, H Isaac, J Mahoney, PF Shewry, L |
author_sort | Thomas, D |
collection | PubMed |
description | 1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared. 4. A fibrinogen < 1 g.l(−1) or a prothrombin time (PT) and activated partial thromboplastin time (aPTT) of > 1.5 times normal represents established haemostatic failure and is predictive of microvascular bleeding. Early infusion of fresh frozen plasma (FFP; 15 ml.kg(−1)) should be used to prevent this occurring if a senior clinician anticipates a massive haemorrhage. 5. Established coagulopathy will require more than 15 ml.kg(−1) of FFP to correct. The most effective way to achieve fibrinogen replacement rapidly is by giving fibrinogen concentrate or cryoprecipitate if fibrinogen is unavailable. 6. 1:1:1 red cell:FFP:platelet regimens, as used by the military, are reserved for the most severely traumatised patients. 7. A minimum target platelet count of 75 × 10(9).l(−1) is appropriate in this clinical situation. 8. Group-specific blood can be issued without performing an antibody screen because patients will have minimal circulating antibodies. O negative blood should only be used if blood is needed immediately. 9. In hospitals where the need to treat massive haemorrhage is frequent, the use of locally developed shock packs may be helpful. 10. Standard venous thromboprophylaxis should be commenced as soon as possible after haemostasis has been secured as patients develop a prothrombotic state following massive haemorrhage. |
format | Text |
id | pubmed-3032944 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2010 |
publisher | Blackwell Publishing Ltd |
record_format | MEDLINE/PubMed |
spelling | pubmed-30329442011-02-15 Blood transfusion and the anaesthetist: management of massive haemorrhage Thomas, D Wee, M Clyburn, P Walker, I Brohi, K Collins, P Doughty, H Isaac, J Mahoney, PF Shewry, L Anaesthesia Guidelines 1. Hospitals must have a major haemorrhage protocol in place and this should include clinical, laboratory and logistic responses. 2. Immediate control of obvious bleeding is of paramount importance (pressure, tourniquet, haemostatic dressings). 3. The major haemorrhage protocol must be mobilised immediately when a massive haemorrhage situation is declared. 4. A fibrinogen < 1 g.l(−1) or a prothrombin time (PT) and activated partial thromboplastin time (aPTT) of > 1.5 times normal represents established haemostatic failure and is predictive of microvascular bleeding. Early infusion of fresh frozen plasma (FFP; 15 ml.kg(−1)) should be used to prevent this occurring if a senior clinician anticipates a massive haemorrhage. 5. Established coagulopathy will require more than 15 ml.kg(−1) of FFP to correct. The most effective way to achieve fibrinogen replacement rapidly is by giving fibrinogen concentrate or cryoprecipitate if fibrinogen is unavailable. 6. 1:1:1 red cell:FFP:platelet regimens, as used by the military, are reserved for the most severely traumatised patients. 7. A minimum target platelet count of 75 × 10(9).l(−1) is appropriate in this clinical situation. 8. Group-specific blood can be issued without performing an antibody screen because patients will have minimal circulating antibodies. O negative blood should only be used if blood is needed immediately. 9. In hospitals where the need to treat massive haemorrhage is frequent, the use of locally developed shock packs may be helpful. 10. Standard venous thromboprophylaxis should be commenced as soon as possible after haemostasis has been secured as patients develop a prothrombotic state following massive haemorrhage. Blackwell Publishing Ltd 2010-11 /pmc/articles/PMC3032944/ /pubmed/20963925 http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x Text en Copyright © 2010 The Association of Anaesthetists of Great Britain and Ireland http://creativecommons.org/licenses/by/2.5/ Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation. |
spellingShingle | Guidelines Thomas, D Wee, M Clyburn, P Walker, I Brohi, K Collins, P Doughty, H Isaac, J Mahoney, PF Shewry, L Blood transfusion and the anaesthetist: management of massive haemorrhage |
title | Blood transfusion and the anaesthetist: management of massive haemorrhage |
title_full | Blood transfusion and the anaesthetist: management of massive haemorrhage |
title_fullStr | Blood transfusion and the anaesthetist: management of massive haemorrhage |
title_full_unstemmed | Blood transfusion and the anaesthetist: management of massive haemorrhage |
title_short | Blood transfusion and the anaesthetist: management of massive haemorrhage |
title_sort | blood transfusion and the anaesthetist: management of massive haemorrhage |
topic | Guidelines |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3032944/ https://www.ncbi.nlm.nih.gov/pubmed/20963925 http://dx.doi.org/10.1111/j.1365-2044.2010.06538.x |
work_keys_str_mv | AT thomasd bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT weem bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT clyburnp bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT walkeri bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT brohik bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT collinsp bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT doughtyh bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT isaacj bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT mahoneypf bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT shewryl bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage AT bloodtransfusionandtheanaesthetistmanagementofmassivehaemorrhage |